BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20574155)

  • 1. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.
    Ringer L; Sirajuddin P; Yenugonda VM; Ghosh A; Divito K; Trabosh V; Patel Y; Brophy A; Grindrod S; Lisanti MP; Rosenthal D; Brown ML; Avantaggiati ML; Rodriguez O; Albanese C
    Cancer Biol Ther; 2010 Aug; 10(4):320-5. PubMed ID: 20574155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.
    Ringer L; Sirajuddin P; Tricoli L; Waye S; Choudhry MU; Parasido E; Sivakumar A; Heckler M; Naeem A; Abdelgawad I; Liu X; Feldman AS; Lee RJ; Wu CL; Yenugonda V; Kallakury B; Dritschilo A; Lynch J; Schlegel R; Rodriguez O; Pestell RG; Avantaggiati ML; Albanese C
    Oncotarget; 2014 Nov; 5(21):10678-91. PubMed ID: 25296977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.
    Ringer L; Sirajuddin P; Heckler M; Ghosh A; Suprynowicz F; Yenugonda VM; Brown ML; Toretsky JA; Uren A; Lee Y; MacDonald TJ; Rodriguez O; Glazer RI; Schlegel R; Albanese C
    Cancer Biol Ther; 2011 Nov; 12(9):818-26. PubMed ID: 21885916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.
    Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C
    Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies for prostate cancer?
    Tanowitz HB; Machado FS
    Cancer Biol Ther; 2010 Aug; 10(4):326-8. PubMed ID: 20703097
    [No Abstract]   [Full Text] [Related]  

  • 9. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells.
    Mantena SK; Sharma SD; Katiyar SK
    Mol Cancer Ther; 2006 Feb; 5(2):296-308. PubMed ID: 16505103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole phytoalexin derivatives induce mitochondrial-mediated apoptosis in human colorectal carcinoma cells.
    Tischlerova V; Kello M; Budovska M; Mojzis J
    World J Gastroenterol; 2017 Jun; 23(24):4341-4353. PubMed ID: 28706417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI.
    Sirajuddin P; Das S; Ringer L; Rodriguez OC; Sivakumar A; Lee YC; Üren A; Fricke ST; Rood B; Ozcan A; Wang SS; Karam S; Yenugonda V; Salinas P; Petricoin E; Pishvaian M; Lisanti MP; Wang Y; Schlegel R; Moasser B; Albanese C
    Cell Cycle; 2012 Oct; 11(20):3801-9. PubMed ID: 22983062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells.
    Gu M; Raina K; Agarwal C; Agarwal R
    Mol Carcinog; 2010 Jan; 49(1):1-12. PubMed ID: 19544333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
    Jiang C; Wang Z; Ganther H; Lü J
    Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis.
    Liou SF; Lin HH; Liang JC; Chen IJ; Yeh JL
    Toxicology; 2009 Feb; 256(1-2):13-24. PubMed ID: 19056458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
    Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
    Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway.
    Park HY; Kim MK; Moon SI; Cho YH; Lee CH
    Cancer Sci; 2006 May; 97(5):430-6. PubMed ID: 16630142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.
    Shankar E; Zhang A; Franco D; Gupta S
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a novel carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleoside on pleiotropic induction of cell death in prostate cancer cells with different androgen responsiveness.
    Suh H; Choi KW; Lee J; Ryou C; Rhee H; Lee CH
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1130-5. PubMed ID: 26832220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.